Scientific Sessions 2024  /  GDMT and Hyperkalemia: A Crossroad for Cardiology Finding an Optimal Path  /  GDMT and Hyperkalemia: A Crossroad for Cardiology Finding an Optimal Path
Logo

American Heart Association

  2
  0

Final ID:

GDMT and Hyperkalemia: A Crossroad for Cardiology Finding an Optimal Path

  • Vaduganathan, Muthiah  ( Brigham and Womens Hospital , Boston , Massachusetts , United States )
    • Author Disclosures:
    Muthiah Vaduganathan: DO have relevant financial relationships ; Researcher:received research grant support, served on advisory boards, or had speaker engagements with American Regent, Amgen, AstraZeneca, Bayer AG, Baxter Healthcare, BMS, Boehringer Ingelheim, Chiesi, Cytokinetics, Lexicon Pharmaceuticals, Merck, Novartis, Novo Nordisk, Pharmacosmos, Relypsa, Roche Diagnostics, Sanofi, and Tricog Health, and participates on clinical trial committees for studies sponsored by AstraZeneca, Galmed, Novartis, Bayer AG, Occlutech, and Impulse Dynamics:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

GDMT and Hyperkalemia: A Crossroad for Cardiology Finding an Optimal Path

Sunday, 11/17/2024 , 12:30PM - 01:15PM

Heart Theater

More abstracts from these authors:
COPD and Cardiopulmonary Risk: A Critical Connection

Vaduganathan Muthiah

PRO: Lightening the Load: Use of GLP-1 Receptor Agonists in Heart Failure

Vaduganathan Muthiah, Borlaug Barry

You have to be authorized to contact abstract author. Please, Login
Not Available